Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals (Nasdaq: CNTA), a clinical-stage pharmaceutical company, has announced its management team's participation in two upcoming investor conferences in June 2025:
- The Jefferies 2025 Global Healthcare Conference on June 4, with a fireside chat at 11:40 AM ET
- The Goldman Sachs 46th Annual Global Healthcare Conference on June 10, with a fireside chat at 9:20 AM ET
Live webcasts and archived recordings of both events will be accessible through the "Events and Publications" section on Centessa's investor relations website.
Centessa Pharmaceuticals (Nasdaq: CNTA), un'azienda farmaceutica in fase clinica, ha annunciato la partecipazione del suo team dirigenziale a due conferenze per investitori previste per giugno 2025:
- La Jefferies 2025 Global Healthcare Conference il 4 giugno, con un incontro informale alle 11:40 ET
- La Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno, con un incontro informale alle 9:20 ET
Le dirette web e le registrazioni archiviate di entrambi gli eventi saranno disponibili nella sezione "Eventi e Pubblicazioni" sul sito web delle relazioni con gli investitori di Centessa.
Centessa Pharmaceuticals (Nasdaq: CNTA), una empresa farmacéutica en etapa clínica, ha anunciado la participación de su equipo directivo en dos conferencias para inversores que se realizarán en junio de 2025:
- La Jefferies 2025 Global Healthcare Conference el 4 de junio, con una charla informal a las 11:40 AM ET
- La Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio, con una charla informal a las 9:20 AM ET
Las transmisiones en vivo y las grabaciones archivadas de ambos eventos estarán disponibles en la sección "Eventos y Publicaciones" en el sitio web de relaciones con inversores de Centessa.
Centessa Pharmaceuticals (나스닥: CNTA), 임상 단계 제약 회사가 2025년 6월에 예정된 두 개의 투자자 컨퍼런스에 경영진이 참여할 예정임을 발표했습니다:
- 6월 4일 Jefferies 2025 Global Healthcare Conference, 오전 11:40 ET에 파이어사이드 채팅 진행
- 6월 10일 Goldman Sachs 46th Annual Global Healthcare Conference, 오전 9:20 ET에 파이어사이드 채팅 진행
두 행사 모두의 생중계 및 녹화본은 Centessa 투자자 관계 웹사이트의 "이벤트 및 출판물" 섹션에서 확인할 수 있습니다.
Centessa Pharmaceuticals (Nasdaq : CNTA), une société pharmaceutique en phase clinique, a annoncé la participation de son équipe de direction à deux conférences pour investisseurs prévues en juin 2025 :
- La Jefferies 2025 Global Healthcare Conference le 4 juin, avec une discussion informelle à 11h40 ET
- La Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin, avec une discussion informelle à 9h20 ET
Les webdiffusions en direct et les enregistrements archivés des deux événements seront accessibles dans la section « Événements et Publications » du site web des relations investisseurs de Centessa.
Centessa Pharmaceuticals (Nasdaq: CNTA), ein biopharmazeutisches Unternehmen in der klinischen Phase, hat die Teilnahme seines Managementteams an zwei bevorstehenden Investorenkonferenzen im Juni 2025 angekündigt:
- Die Jefferies 2025 Global Healthcare Conference am 4. Juni mit einem Fireside Chat um 11:40 Uhr ET
- Die Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni mit einem Fireside Chat um 9:20 Uhr ET
Live-Webcasts und archivierte Aufzeichnungen beider Veranstaltungen sind im Bereich „Veranstaltungen und Publikationen“ auf der Investor-Relations-Website von Centessa verfügbar.
- None.
- None.
BOSTON and LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:
Event: Jefferies 2025 Global Healthcare Conference
Date: June 4, 2025
Fireside Chat: 11:40 AM ET
Event: Goldman Sachs 46th Annual Global Healthcare Conference
Date: June 10, 2025
Fireside Chat: 9:20 AM ET
Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals, plc is a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. We are pioneering a new class of potential therapies within our orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits and fatigue across neurological, neurodegenerative and neuropsychiatric disorders. We also have an early-stage immuno-oncology program focused on our novel LockBody® technology platform. For more information, visit www.centessa.com, which does not form part of this release.
Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com
FAQ
When is Centessa Pharmaceuticals (CNTA) presenting at the Jefferies Healthcare Conference 2025?
What time is CNTA's presentation at the Goldman Sachs Healthcare Conference 2025?
How can investors access Centessa Pharmaceuticals' conference presentations?
Which investor conferences is Centessa Pharmaceuticals (CNTA) attending in June 2025?
